in an insulin-dependent diabetic were attributed to surreptitious self-administration of insulin. Immunoreactive c-peptide values were falsely increased and diagnostically misleading when measured in unextracted plasma. After preliminary removal of antigen/antibody complexes from the plasma by extraction with polyethylene glycol, the c-peptide values, referred to as ' 'free cpeptide,' ' were suppressed. We suggest that insulin antibodies formed complexes with proinsulin-like material in the plasma of this patient, which accounted for most of the c-peptide immunoreactivity in her unextracted plasma. These complexes must be removed if c-peptide measurements are to be accurate.
During the enzymatic cleavage of precursor proinsulin, most of the connecting chain remains intact and enters the circulation in an equimolar ratio with insulin (1). This peptide has been designated as "connecting peptide" or "c-peptide. Table 2 . Shortly thereafter, a bottle of U-500 insulin was found taped to the bottom of the chair at her bedside and she admitted to injecting herselfwith as much as 1500 USP units of insulin in a single dose.
Materials and Methods
Double-antibody radioimmunoassay procedures were used for insulin and c-peptide determination (9, 10). The interassay coefficient of variation (CV) of insulin at the concentration of 12 milliunits/L was 10%, and the mean normal concentration during fasting was 14 (SD 5, range 4-24 milliunitslL).
The interassay CV for c-peptide at the concentration of 2 ig/L was 6.8%, and the mean fasting normal concentration was 2.6 (SD 0.8, range, 1-4.2) tgIL. The sensitivity of the assay was 4 milliunits for insulin and 0.25 g/L for c-peptide.
Free and total hormone concentrations were measured by preliminary precipitation of the plasma with PEG as previ-
ously described (II, 12). For the determinations
of total insulin and total c-peptide, the immune complexes were dissociated by adding 0.2 mL of 1 mol/L HC1 to 1 mL of serum and incubating at room temperature for 1 h. The serum pH was then neutralized with 0.2 mL of I mol/L NaOH. The antibodies were precipitated by adding 1 mL of PEG (250 g/L), mixing vigorously, and centrifuging at 3000 rpm for 30 mm. The supernatant fluid, containing all of the insulin and cpeptide in uncomplexed form, was then used to perform cpeptide and insulin immunoassays. Total c-peptide concentrations measured in this manner were identical to those obtained when c-peptide was measured directly in unextracted plasma. For the determinations of free insulin and free c-peptide, we added 1 mL of cold PEG to 1 mL of plasma to precipitate the antibody complexes without prior acidic dissociation. The samples were mixed vigorously and centrifuged as above. The supernates, containing only the insulin and c-peptide that had been originally uncomplexed, were then used directly in the immunoassays.
We assessedthe presence of insulin antibody by measuring the binding of serum to 1251-labeled insulin. The results are expressed as percent binding. Nonspecific binding, estimated with normal human serum, was less than 5%.
Discussion
The only laboratory measurement that is useful for the diagnosis of self-induced hypoglycemia in an insulin-dependent diabetic is serum c-peptide (13). When c-peptide con- At comparable levels of hypoglycemia, however, the c-peptide is much less decreased in the diabetics (14). Thus, diabetics may be less able to suppress c-peptide secretion during hypoglycemia as compared to normal subjects. Furthermore, the half-life of c-peptide in plasma is much longer in insulindependent diabetics than in normal subjects (15) Harwood (23) reports an interesting case of exogenous hyperinsulinism in an insulin-dependent diabetic who suffered profound episodes of hyjxglycemia on a predictable, monthly basis. After radioiodination of her insulin, they detet ed radioactive components in her urine on the days of hypoglycemia when no insulin had been administered.
One theory was that cyclical over-saturation of her insulin antibodies resulted in more free insulin, which is metabolically active, and produced hypoglycemia.
As the excess insulin was metabolized, her hyperglycemia resumed, necessitating the further use of insulin. The cycle was then repeated. In our patient, periods of insulin excess were not predictable. However, the possibility that insulin antibodies provide a reservoir of insulin that periodically dissociates, resulting in hypoglycemia, cannot be excluded on the basis of our data. In such an event, c-peptide values would also be suppressed. In this case, the release of insulin by insulin/antibody complexes would play a minor role, if any, in view of the clinical setting in which the diagnosis was verified.
Another possibility that we excluded was familial hyperproinsulinemia, described by Gabbay et al. (24) . We found no evidence for proinsulin-like material in the plasma of our patient's family. Our case illustrates the need for removal of proinsulin bound to insulin antibodies before c-peptide is measured in the serum of a diabetic who is on insulin therapy (or a nondiabetic who may have used insulin to induce hypoglycemia). Although free and total c-peptide values may not differ substantially in all diabetics, the combination of factors outlined here may have been responsible for the spuriously high total c-peptide concentrations in this patient.
